Peripartum heart failure in a patient treated previously with doxorubicin.
Postpartum congestive heart failure developed in a primigravida seven years after doxorubicin therapy for osteosarcoma. Delayed cardiac toxicity may be affected by preeclampsia, anemia, or postoperative fluid management.